Bain Capital Life Sciences Investors LLC reduced its holdings in 2seventy bio, Inc. (NASDAQ:TSVT – Free Report) by 5.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,331,801 shares of the company’s stock after selling 77,100 shares during the quarter. 2seventy bio comprises 0.5% […]